Keyword: Boehringer Ingelheim

Though the top prize eluded the field, 10 pharma companies racked up gold, silver or bronze Lions for their marketing and advertising efforts.

In a phase 3 study, Novo said oral semaglutide helped diabetes patients manage their blood sugar levels better than Jardiance. 

Portola has won FDA approval of Andexxa, its antidote for some next-gen bloodthinners, but a manufacturing upgrade will limit initial supplies.

Boehringer Ingelheim recently expanded its RespiPoints online rewards program because it works, with adherence of over 50% after nine months. Now, four of its respiratoy drugs to treat COPD and asthma are on the program, run in conjunction with HealthPrize.

Other bidders may have dropped out of an auction for Sanofi's European generics unit, but that doesn't mean it hasn't found a buyer.

A year after tapping a former Yankees star for its "Breathless" push, Boehringer Ingelheim had another surprise for baseball fans this opening day.

Sanofi is out another potential buyer for its European generics business as India-based Torrent Pharma exited deal talks, according to a report.

Boehringer Ingelheim wants to move its drug nintedanib into the scleroderma market. Meanwhile, it’s working to expand awareness of the disease, too.

As Sanofi presses ahead with the sale of its EU generics unit, a private equity firm has reportedly bowed out over price.